AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18235115
Drug: Imatinib (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (500 mg/d) in mild liver dysfunction group
Trial: 16038686
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg total dose group (four-100 microg injections over eight weeks)
Trial: 16038686
Drug: 2000 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 microg total dose group (five-400 microg vaccinations over twelve weeks)
Trial: 12521655
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (30 microg ethynyl estradiol and 150 microg levonorgestrel)
Trial: 9279980
Drug: PROG alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROG alone (200 mg PROG twice a day for 3 days)
Trial: 9279980
Drug: PROG and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROG and ATQ (200 mg PROG and 500 mg ATQ twice a day for 3 days)
Trial: 28092065
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg preoperatively followed by five 200 mg doses every 12 hours)
Trial: 28092065
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no anti-inflammatory agents)
Trial: 23103551
Drug: Rotigotine treatment
RxNorm normalized name: Rotigotine
DrugBank: Rotigotine (DB05271)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rotigotine treatment (up to 3 mg/24 h after an 8-week titration phase)
Trial: 21370724
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg once daily for 6 weeks
Trial: 12515103
Drug: Trimetazidine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (60 mg)
Trial: 12515103
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (60 mg)
Trial: 2650729
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml (75 mg) bupivacaine
Trial: 2650729
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml (112.5 mg) bupivacaine
Trial: 22948416
Drug: Atorvastatin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin plus diet therapy
Trial: 21223542
Drug: Neramexane 50
RxNorm normalized name: Neramexane
DrugBank: Neramexane (DB04926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neramexane 50 mg/day
Trial: 21223542
Drug: Neramexane 75
RxNorm normalized name: Neramexane
DrugBank: Neramexane (DB04926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neramexane 75 mg/day
Trial: 21223542
Drug: Neramexane 25
RxNorm normalized name: Neramexane
DrugBank: Neramexane (DB04926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neramexane 25 mg/day
Trial: 11197651
Drug: EHF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHF therapy (group 1)
Trial: 11197651
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (group 2)
Trial: 11197651
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of laser with EHF‐puncture (group 3)
Trial: 9120155
Drug: 6 mmol
RxNorm normalized name: monobasic potassium phosphate 6 MMOL/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mmol of magnesium/12 mmol of potassium-DL-hydrogenaspartate daily
Trial: 25590292
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (Control group) (n = 26)
Trial: 20381924
Drug: Intervention by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention by a peer (patient on antiretroviral therapy)
Trial: 20381924
Drug: Patients receiving
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients receiving a drug combination including a protease inhibitor
Trial: 18753118
Drug: Lopinavir/ritonavir capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir capsules (once or twice daily) with tenofovir DF and emtricitabine (both once daily) for 96 weeks
Trial: 12192262
Drug: Selective cyclo-oxygenase
RxNorm normalized name: cyclo-D-Serine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective cyclo-oxygenase inhibitors (COX-II)
Trial: 9989555
Drug: Nortriptyline alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline alone in a medication clinic (N = 25)
Trial: 9989555
Drug: Placebo alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo alone in a medication clinic (N = 22)
Trial: 7373080
Drug: Inactivated B/Hong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated B/Hong Kong virus vaccine
Trial: 7373080
Drug: Hemagglutination‐inhibiting antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemagglutination‐inhibiting antibody response
Trial: 15320956
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg escitalopram daily
Trial: 17921381
Drug: 50,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50,000 IU vitamin A administered with BCG vaccine at birth
Trial: 8712116
Drug: Lidocaine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1.5 mg/kg intravenously in 2 minutes)
Trial: 8712116
Drug: Procainamide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procainamide (10 mg/kg intravenously at an injection speed of 100 mg/min)
Trial: 20428608
Drug: Lodenafil carbonate
RxNorm normalized name: Lodenafil carbonate
DrugBank: Lodenafil carbonate (DB11927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodenafil carbonate (160 mg) with alcohol
Trial: 20428608
Drug: Lodenafil carbonate
RxNorm normalized name: Lodenafil carbonate
DrugBank: Lodenafil carbonate (DB11927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodenafil carbonate (160 mg) alone
Trial: 18803991
Drug: MON 5-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MON 5-mg tablet QD
Trial: 11799078
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion (1 g/min; total 30 g)
Trial: 11799078
Drug: Hydralazine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine infusion (control)
Trial: 6662724
Drug: High initial
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High initial dosage of oral aromatic retinoid (75 mg leads to 50 leads to 35 mg; approximately 1 mg/kg/d leads to approximately 0.5 mg/kg/d)
Trial: 6662724
Drug: Low initial
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low initial dosage of oral aromatic retinoid (35 mg leads to 50 mg/d leads to 75 mg/d; approximately 0.5 mg/kg/d leads to approximately 1.0 mg/kg/d)
Trial: 6662724
Drug: Moderate doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate doses of oral aromatic retinoid (35-60 mg/d; approximately 0.4-0.8 mg/kg/d)
Trial: 6662724
Drug: High initial
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High initial dosage of retinoid
Trial: 30539282
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy combined with intravesical chemotherapy (Group A, n=68)
Trial: 30539282
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy alone (Group B, n=135)
Trial: 28122931
Drug: 50,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50,000 IU vitamin D supplements every 2 weeks for 6 months
Trial: 25689146
Drug: AFQ056 (25-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AFQ056 (25-150 mg, twice-daily)
Trial: 25022106
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (aniracetam tablets, 0.2 g twice a day)
Trial: 9188228
Drug: Evidence-based periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based periodontal therapy
Trial: 3548985
Drug: Diflunisal (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflunisal (500 to 750 mg daily, increased to a maximum of 1 gm daily during the open-label phase)
Trial: 3548985
Drug: Aspirin (2.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (2.6 to 3.9 gm daily)
Trial: 21791491
Drug: Angiotensin receptor
RxNorm normalized name: Angiotensin receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor blockade (valsartan 320 mg/day) plus regular sodium diet (200 mmol Na(+)/day)
Trial: 21791491
Drug: Angiotensin receptor
RxNorm normalized name: Angiotensin receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor blockade (valsartan 320 mg/day) plus low sodium diet (50 mmol Na(+)/day)
Trial: 21791491
Drug: ACE inhibition
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibition (lisinopril 40 mg/day) plus regular sodium diet (200 mmol Na(+)/day)
Trial: 21791491
Drug: ACE inhibition
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibition (lisinopril 40 mg/day) plus low sodium diet (50 mmol Na(+)/day)
Trial: 21791491
Drug: ACE inhibition
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibition (lisinopril 40 mg/day) plus angiotensin receptor blockade (valsartan 320 mg/day)
Trial: 11552907
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 420 mg
Trial: 11552907
Drug: Antacid alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid alone
Trial: 11552907
Drug: Ranitidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine plus antacid
Trial: 7818585
Drug: roxatidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxatidine (150 mg daily) with diclofenac (100 mg daily)
Trial: 7818585
Drug: diclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac (100 mg daily) with placebo
Trial: 7818585
Drug: misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: misoprostol (200 micrograms bid) with diclofenac (100 mg daily)
Trial: 7818585
Drug: diclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac (100 mg daily) with roxatidine (150 mg daily)
Trial: 3276865
Drug: Plasma infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma infusion (P+ group)
Trial: 3276865
Drug: Symptomatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic therapy (P- group)
Trial: 24018103
Drug: Interaction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interaction of rs363224 with D2 receptor rs6277 (C957T) polymorphism
Trial: 18006647
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of [(14)C]dabigatran etexilate (oral prodrug)
Trial: 18006647
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of [(14)C]dabigatran (i.v. infusion)
Trial: 11118564
Drug: Sertaconazole 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertaconazole 300 mg suppository
Trial: 11118564
Drug: Econazole 150
RxNorm normalized name: oteseconazole 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Econazole 150 mg suppository
Trial: 8475322
Drug: Other hypnotics
RxNorm normalized name: Other hypnotics and sedatives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other hypnotics
Trial: 8475322
Drug: Residual effects
RxNorm normalized name: antihemophilic factor, human recombinant residues 743-1636 deleted Injection [Xyntha]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Residual effects of hypnotics
Trial: 2417648
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy (US) at 1.5 W.cm-2
Trial: 2417648
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy (US) at 0.1 W.cm-2
Trial: 2417648
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy (US) at 0.5 W.cm-2
Trial: 29788802
Drug: Inhaled menthol
RxNorm normalized name: menthol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled menthol (0.0%, 0.5%, and 3.2%)
Trial: 29788802
Drug: Saline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline and nicotine infusions (0.25 mg and 0.5 mg/70 kg)
Trial: 18208463
Drug: 0.1% methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% methylprednisolone aceponate cream + emollients (Group B)
Trial: 18208463
Drug: 0.1% methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% methylprednisolone aceponate cream (Group A)
Trial: 10753981
Drug: Conventional-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-intensity warfarin therapy (INR 2.2 to 3.5)
Trial: 10753981
Drug: Low-intensity warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity warfarin therapy (INR 1.5 to 2.1)
Trial: 3555359
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate 50 mg intramuscularly every third week for two years
Trial: 3555359
Drug: No anabolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anabolic steroids (Control)
Trial: 25677642
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir plus sitagliptin
Trial: 23545909
Drug: Tretinoin 0.025%/clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% foaming cloth
Trial: 23545909
Drug: Tretinoin 0.025%/clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.025%/clindamycin phosphate 1.2% gel alone
Trial: 10629624
Drug: Pamidronate 60
RxNorm normalized name: pamidronate 60 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 60 mg i.v. q 4 weeks
Trial: 1933707
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel (0.5 mg in 2.5 mL)
Trial: 1933707
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel (2.5 mL)
Trial: 7141686
Drug: Live influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1[E] (38 degrees C shut‐off temperature)
Trial: 7141686
Drug: Live influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1A2 (37 degrees C shut‐off temperature)
Trial: 7141686
Drug: Live influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines with cold‐adapted A/Ann Arbor/6/60
Trial: 7141686
Drug: Live influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines
Trial: 7141686
Drug: Unvaccinated volunteers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unvaccinated volunteers with little or no serum antibody
Trial: 29461654
Drug: Structured aerobic
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured aerobic and resistance exercise program performed twice per week, including 20 minutes of aerobic exercise, 20-25 minutes of resistance exercise, and 10 minutes of cool down.
Trial: 28178072
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac + 1.2 mg atropine
Trial: 28178072
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 1.2 mg atropine
Trial: 28178072
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac + placebo
Trial: 24392486
Drug: Multidirectional FRC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidirectional FRC groups (g to l)
Trial: 21180658
Drug: Glucocorticoid administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucocorticoid administration
Trial: 16791287
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maximum medical treatment)
Trial: 3542942
Drug: Ciprofloxacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (100 mg bd for five days)
Trial: 3542942
Drug: Trimethoprim (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (200 mg bd for five days)
Trial: 12823643
Drug: B-vitamins (folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-vitamins (folic acid 2 mg and vitamin B12 1 mg)
Trial: 12823643
Drug: Antioxidant vitamins
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamins (vitamin E 500 mg and vitamin C 200 mg)
Trial: 10910802
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of hydrocortisone
Trial: 10910802
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg of ovine CRH
Trial: 8955969
Drug: Terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5 mg in 2 ml normal saline)
Trial: 22503786
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (4 ml)
Trial: 8955969
Drug: Atropine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.01 mg.kg-1, iv)
Trial: 3837132
Drug: Prostin 15-M
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostin 15-M (8.92 ml, 28h 30' for group A; 8.23 ml, 23h 23' for group B; 4.97 ml, 16h for group C)
Trial: 28462869
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) given for 5 months in blended form (face-to-face and web-based sessions)
Trial: 27507989
Drug: 5% curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% curcumin oral paste three times a day for four weeks
Trial: 23322191
Drug: Epidural methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural methadone 2.5 mg with 40 mg lidocaine
Trial: 23322191
Drug: Epidural methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural methadone 5 mg with 40 mg lidocaine
Trial: 23322191
Drug: Epidural methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural methadone 7.5 mg with 40 mg lidocaine and 10 mg dexamethasone
Trial: 22183840
Drug: Episodic acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Episodic acyclovir therapy
Trial: 10719650
Drug: Intra-arterial thrombolytic
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial thrombolytic therapy
Trial: 30853042
Drug: Sleep health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sleep health program (4 weekly group sessions)
Trial: 29740768
Drug: Recommended dose
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended dose of NPK (control)
Trial: 26250435
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (iron sulphate, 200 mg daily for 8 weeks)
Trial: 22990269
Drug: High-dose aerobic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose aerobic training (40 min/d; n = 73)
Trial: 22990269
Drug: Low-dose aerobic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aerobic training (20 min/d; n = 71)
Trial: 17439905
Drug: Fampridine-SR (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fampridine-SR (10 to 40 mg twice daily, increasing in 5 mg increments weekly)
Trial: 15055251
Drug: Bedtime administration
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime administration of trandolapril
Trial: 15055251
Drug: Morning administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning administration of trandolapril
Trial: 9695314
Drug: ipriflavone 600
RxNorm normalized name: IPRIFLAVONE
DrugBank: Ipriflavone (DB13618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipriflavone 600 mg/day (OSTEN)
Trial: 9695314
Drug: daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: daily oral administration of 2 g calcium lactate and 0.5 microgram alphacalcidol (Ca.D)
Trial: 9695314
Drug: repeated 14‐week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: repeated 14‐week cycle of daily oral administration of 2 micrograms alphacalcidol for 2 weeks, 600 mg of ipriflavone for 4 weeks, and 2 g calcium lactate together with 0.5 microgram alphacalcidol for 8 weeks (ADFR)